About the Global Burden of Disease The Lancet Oncology

The GBD study offers a powerful resource to understand the changing health challenges facing people across the world in the 21st century. Led by the Institute for Health Metrics and Evaluation (IHME), the GBD study is the most comprehensive worldwide observational epidemiological study to date. By tracking progress within and between countries GBD provides an important tool to inform clinicians, researchers, and policy makers, promote accountability, and improve lives worldwide. https://www.thelancet.com/gbd?dgcid=hubspot_update_feature_updatealerts_lanonc&utm_campaign=update-lanonc&utm_medium=email&_hsenc=p2ANqtz--DdAi8OeR3KfE7TrK6feFnOGdwlwAc5RY_3q7pjigpLdrt_F0-ZWGPuymFaoBWgAAImh7LOsy2fqKFO3yMYYwPpmIxHA&_hsmi=333363116&utm_content=333359314&utm_source=hs_email